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Geneticist Razib Khan's decision to obtain the whole genome sequence of his partner's fetus in utero 
shows us that genomics is no longer a fantasy. While it would be a mistake to use this one example 
to condemn the entire practice of whole genome sequencing (WGS) prior to birth, I will suggest here 
why we should look before we leap regarding prenatal WGS. 
If you lean towards the permissive with respect to genomics, this sequencing event may not be a big 
deal. Genomic sequencing technology is now fast and cheap. Long-held paradigms such as non-
directiveness and respecting children's future autonomy may no longer apply when sequence 
information is becoming almost mundane and is striding into new healthcare domains. 
Presumptions of bodily integrity and reproductive autonomy in pregnancy may further diminish 
concerns – after all, we have very few justifiable thresholds for interfering in decision-making during 
pregnancy and the harm to the future child that may occur here would be unlikely to reach them. 
I think a bit differently to this and advocate a (future) child-centred approach; one which rejects 
technological imperatives to obtain whole sequences before birth just because we can. WGS will 
soon be cheaper than testing for one or a few genes and this is certainly a welcome development. 
But while high throughput methods might be chosen, they should not necessarily dictate the 
information that is provided. Genomics will bring a significant change in the volume of information 
received and we won't know for some time what it all means. Genomics also won't ever be able to 
tell us everything about our health. While Khan may have been able to analyse his son's own 
genome, this skill will not be within everyone's reach. And while genome sequencing is cheap, 
interpretation and data storage are not. 
Current practice regarding the provision of predictive genetic information to children is helpful. 
Generally, carers are dissuaded from obtaining information irrelevant to health in early childhood, 
before the child herself can participate in decision-making. This position is based on considerations 
such as the future autonomy of the child to decide for herself, the child's future being as 'open' as 
possible and other welfare-based considerations. 
I also claim that the current presumptions in prenatal testing, which distinguish between serious and 
minor conditions and include a commitment to shared decision-making, can still serve as a useful 
guide. They are certainly not perfect, but can and should remain relevant as we enter the genomics 
era. So before we seek a whole genome in a fetus, I'd suggest the following points for reflection: 
 Why do we want to know this information? What is its utility in the prenatal context? 
 What benefit will this information have during pregnancy? Why test now? 
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 Is there a medical indication for testing? 
 Would it be in the future adult's interests for his or her genome to be determined now? 
Obtaining whole genomes may well be valuable and important to global health. However the 
prenatal context is not the only time this can be done. If sequencing (ideally due to medical 
indication) is undertaken, analysis can be limited and the sequence can then be destroyed. An 
individual can then decide whether to be re-sequenced, once she has the capacity to do so (1).  
Are these claims proving too much? That is, in advocating that a genome should belong to the future 
adult that this fetus will become, will the result be that a woman or couple should not be able to 
make any decisions that affect a fetus, including termination of pregnancy? 
In a forthcoming paper, my colleagues and I address this issue (2). We claim that it is possible to be 
both pro-choice and seek to place limits on the information that a couple can obtain about a child 
prior to birth, particularly in cases like Khan's where there seemed no intention to terminate the 
pregnancy (as the information was obtained in the third trimester). If a woman or couple intends to 
continue a pregnancy regardless of the information received, then the above claims can apply. The 
fetus is, all being well, destined to become a future adult who will have rights and interests. This 
does not mean that a fetus will always have rights that override those of its parents, but in 
circumstances such as WGS for information only they are relevant and may override those of the 
couple. 
My position of caution and child-centredness over prenatal WGS is not absolute and is consistent 
with others working in the field (3). The presumption should be against prenatal WGS, but 
justifications for testing reached using the above points for consideration, together with 
consideration of sound evidence and after appropriate discussion with an inter-disciplinary team 
could lead to testing going forward. 
Children born into the WGS age will have the rest of their lives to come to grips with their genomes, 
at an appropriate time and with sound clinical oversight. Let's preserve these opportunities as best 
we can. 
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